Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Pyŏrälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G.

Diabetes Care. 1997 Apr;20(4):614-20. Erratum in: Diabetes Care 1997 Jun;20(6):1048.

PMID:
9096989
2.
3.

Statin trials and goals of cholesterol-lowering therapy after AMI.

Pedersen TR.

Am Heart J. 1999 Aug;138(2 Pt 2):S177-82. Review.

PMID:
10426879
4.

Cholesterol reduction yields clinical benefits: meta-analysis including recent trials.

Gould AL, Davies GM, Alemao E, Yin DD, Cook JR.

Clin Ther. 2007 May;29(5):778-94. Review.

PMID:
17697899
5.

The 4S study. Implications for prescribing.

van Boven AJ, Brügemann J, de Graeff PA, May JF, Crijns HJ.

Drugs. 1996 Apr;51(4):507-14. Review.

PMID:
8706591
6.

Diabetic dyslipidemia.

Kreisberg RA.

Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. Review.

PMID:
9915665
7.
8.

Review of cholesterol-lowering therapy: coronary angiographic and events trials.

Waters D, Pedersen TR.

Am J Med. 1996 Oct 8;101(4A):4A34S-38S; discussion 39S. Review.

PMID:
8900335
10.

Atorvastatin: its clinical role in cerebrovascular prevention.

Gaspardone A, Arca M.

Drugs. 2007;67 Suppl 1:55-62. Review.

PMID:
17910521
11.

Lovastatin and simvastatin prevention studies.

Jones PH.

Am J Cardiol. 1990 Sep 18;66(8):39B-43B. Review.

PMID:
2206035
12.

Trials of lipid-lowering therapy in secondary prevention of coronary heart disease.

Olsson AG, Pedersen T, Bergdahl B.

Curr Opin Lipidol. 1995 Dec;6(6):369-73. Review.

PMID:
8750250
13.

Effects of lipid-lowering therapy on total and coronary mortality.

Holme I.

Curr Opin Lipidol. 1995 Dec;6(6):374-8. Review.

PMID:
8750251
14.

Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review.

Barth JH, Jackson BM, Farrin AJ, Efthymiou M, Worthy G, Copeland J, Bailey KM, Romaine SP, Balmforth AJ, McCormack T, Whitehead A, Flather MD, Nixon J, Hall AS; SPACE ROCKET Trial Group.

Clin Chem. 2010 Oct;56(10):1592-8. doi: 10.1373/clinchem.2010.145631. Epub 2010 Aug 20. Review.

15.

[Hypercholesterolemia and coronary disease: intervention strategies].

Brunelli C, Spallarossa P, Saccani A, Corsiglia L, Ghigliotti G, Caponnetto S.

Cardiologia. 1991 Dec;36(12 Suppl 1):303-8. Review. Italian.

PMID:
1841785
16.

Clinical relevance of statins: their role in secondary prevention.

Tonkin AM.

Atheroscler Suppl. 2001 Feb;2(1):21-5. Review.

PMID:
11286152
17.

Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.

Costa J, Borges M, David C, Vaz Carneiro A.

BMJ. 2006 May 13;332(7550):1115-24. Epub 2006 Apr 3. Review.

18.
19.

[Primary and secondary prevention of atherosclerotic disease by lipid-lowering therapies].

Mabuchi H.

Nihon Rinsho. 1999 Dec;57(12):2807-14. Review. Japanese.

PMID:
10638217

Supplemental Content

Support Center